CoronaVac, also known as the Sinovac inactivated SARS-CoV-2 vaccine, has been widely
implemented in combating the COVID-19 pandemic. We summarized the results of clinical …

Background The emergence of highly transmissible SARS-CoV-2 variants has led to surges
in cases and the need for global genomic surveillance. While some variants rapidly spread …

Background In view of limited evidence that specifically addresses vaccine effectiveness
(VE) in the older population, this study aims to evaluate the real-world effectiveness of …

A growing number of re-infections with severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) in previously immunized individuals has sparked discussions about the …

Background Indigenous people have historically suffered devastating impacts from
epidemics and continue to have lower access to healthcare and be especially vulnerable to …

The emergence of highly transmissible SARS-CoV-2 variants has led to surges in cases and
the need for global genomic surveillance. While some variants rapidly spread worldwide …

We assessed the circulation of severe acute respiratory syndrome coronavirus‐2 variants
amongst vaccinated military personnel in Bogotá, Colombia to evaluate the mutations of …

Abstract Background In Thailand, early vaccination initiatives for SARS-CoV-2 relied on
CoronaVac (Sinovac Life Sciences) and ChAdOx1 (Oxford–AstraZeneca) vaccines …

Abstract The Health Department is responsible for distributing COVID-19 vaccines in the
region. This research was conducted to evaluate the suitability of storage and distribution …

Introduction: COVID-19 caused by SARS-CoV2 was declared a pandemic by WHO in March
2020 following which many vaccines were synthesised which effectively reduced the case …